Ideaya Biosciences Inc (IDYA) Stock Analysis

Ideaya Biosciences Inc (IDYA) is a publicly traded company in the HEALTHCARE sector. It trades at $27.87, carries a market capitalization of $2.54B. This page summarizes the public market data, fundamentals, and frequently asked questions for IDYA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Ideaya Biosciences Inc currently has a Bullish sentiment score of 0.41.

About Ideaya Biosciences Inc

Ideaya Biosciences, Inc. (NASDAQ: IDYA) is a leading precision medicine oncology company based in South San Francisco, California, focused on developing targeted therapies that optimize patient outcomes through molecular diagnostics. The company specializes in the concept of synthetic lethality, creating innovative treatments that specifically target cancer cells with unique genetic markers, thereby addressing significant unmet needs in oncology. By combining its expertise in advanced biomark...

GNG Research Analysis

GNG Research scores Ideaya Biosciences Inc (IDYA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IDYA.

Frequently Asked Questions

Does IDYA pay dividends?

Ideaya Biosciences Inc (IDYA) does not currently pay a regular dividend.

What is IDYA's market cap?

Ideaya Biosciences Inc (IDYA) has a market capitalization of $2.54B with a current stock price of $27.87.